表紙
市場調査レポート

ハンチントン病:主要8カ国の市場予測

Huntington's Disease Forecast in 8 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339882
出版日 ページ情報 英文 36 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
ハンチントン病:主要8カ国の市場予測 Huntington's Disease Forecast in 8 Major Markets 2015-2025
出版日: 2015年08月01日 ページ情報: 英文 36 Pages
概要

ハンチントン病は先天性・常染色体優位性の疾患で、進行すると神経機能の劣化・障害を引き起こします。中年期に発症する件数が最も多く、また生存期間は発症時の年齢に比例する傾向にあります。

当レポートでは、世界の主要8ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本) におけるハンチントン病の発症状況について分析し、疾患の概要や現時点での有病者数、障害の内容・重度別および性別・年代別 (5歳区切り) の詳細状況、地域別・民族別傾向、リスク要因、疾患の診断と予後、主な症状や合併症、将来的な動向見通し (今後10年間分) といった情報を取りまとめてお届けいたします。

目次

  • イントロダクション
  • 疾患の原因
  • リスク要因と予防法
  • 疾患の診断
  • 地域別/民族別の差異
  • 疾患の予後と臨床経過
  • UHDRS (ハンチントン病統一評価尺度)
  • 全体的な機能的能力
  • 分析手法
  • ハンチントン病の最大有病者数
  • ハンチントン病の有病者数:UHDRSによる障害の種類・重度別の内訳
    • 全体的な機能的能力の段階別の内訳
    • 運動機能障害の有病者数
    • 行動障害の有病者数
    • 認知障害の有病者数
  • 参考文献
  • 付録
目次
Product Code: HUND0010815

Summary

Huntington's disease is an inherited autosomal dominant condition and its progression leads to a deteriorative neurological disorder. Middle age is the more frequent age onset of this disease and is linked with duration of survival. This report provides the current prevalent population for Huntington's disease across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a 10-year forecast projection based on population trends in each of the major markets. The report also contains a disease overview including risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Huntington's patients have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Huntington's disease include:

  • Total functional capacity by stage
  • Nervous system dysfunction
  • Psychiatric disorders
  • Cognitive disorders
  • Major depressive disorder
  • Personality changes
  • Anxiety disorders
  • Nocturia
  • Moderate / Severe Sleep disturbance

The report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in the global Huntington's disease market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of WG and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a greater understanding of the level of impact from specific co-morbid conditions on the Huntington's disease prevalent population.
  • Identify sub-populations within Huntington's disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Huntington's disease patients.

Table of Contents

  • List of Tables & Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Unified Huntington's Disease Rating Scale (UHDRS)
  • Total Functional Capacity
  • Methodology
  • Top-Line Huntington's Disease Prevalence
  • Prevalence of UHDRS Components within the Huntington's Disease Cohort
    • Total Functional Capacity Stage Breakdown
    • Prevalence of Motor Dysfunction in Huntington's Patients
    • Prevalence of Behavioural Dysfunction in Huntington's Patients
    • Prevalence of Cognitive dysfunction in Huntington's Patients
  • References
  • Appendix

List of Tables & Figures

  • Total functional capacity scores and stages
  • Prevalence of Huntington's Disease, total (000s)
  • Prevalence of Huntington's Disease, males (000s)
  • Prevalence of Huntington's Disease, females (000s)
  • Huntington's Disease by TFC stage (000s)
  • Huntington's Disease patients with autonomic nervous system dysfunction (000s)
  • Huntington's Disease patients with psychiatric disorders (000s)
  • Huntington's Disease patients with major depressive disorder (000s)
  • Huntington's Disease patients with personality changes (000s)
  • Huntington's Disease patients with any anxiety disorder (000s)
  • Huntington's Disease patients with cognitive disorders (000s)
  • Huntington's Disease patients with nocturia (000s)
  • Huntington's Disease patients with moderate o severe sleep disturbance (000s)
  • USA Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • USA Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • France Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • France Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • Germany Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • Germany Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • Italy Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • Italy Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • Spain Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • Spain Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Huntington's by 5-yr age cohort, females (000s)
  • Japan Prevalence of Huntington's by 5-yr age cohort, males (000s)
  • Japan Prevalence of Huntington's by 5-yr age cohort, females (000s)
Back to Top